coffeekai/iStock via Getty Images
- BriaCell Therapeutics (NASDAQ:BCTX) priced an underwritten public offering of 7.4M shares and warrants to purchase 7.4M shares.
- The warrants will have an exercise price of $0.9375 per share.
- Total gross proceeds from the offering are expected to be approximately $5.55M.
- The